A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The main purpose of this study is to compare the disease-free survival between participants receiving treatment with TAR-210 versus investigator\'s choice of intravesical chemotherapy for treatment of intermediate-risk NMIBC.
Epistemonikos ID: 914a4b9dd9f28a4a53c6f4089060e102188f4e97
First added on: May 15, 2024